Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income	$ 276,389	$ 196,650
Adjustments to reconcile net income to net cash provided by operating activities:
Loss/(gain) on sale of assets and other	(1,227)	(38)
Depreciation and amortization	44,521	33,192
Noncash lease expense	7,982	7,237
Inventory step-up expense	12,151	0
(Gain) Loss in equity method investment, before tax	(229)	2,289
Deferred income taxes	(13,156)	1,197
Noncash compensation related to stock plans	12,986	13,391
Provision for doubtful accounts	1,146	74
Deferred hedge gain	(1,571)	0
Changes in operating assets and liabilities (net of amounts acquired from ETANCO. see Note 3)
Trade accounts receivable	(55,037)	(73,219)
Inventories	(27,732)	(104,223)
Trade accounts payable	4,960	15,527
Other current assets	(5,711)	(11,272)
Accrued liabilities and other current liabilities	25,283	45,924
Other noncurrent assets and liabilities	(17,359)	(4,631)
Net cash provided by operating activities	263,396	122,098
Cash flows from investing activities
Capital expenditures	(41,571)	(31,285)
Acquisitions, net of cash (see Note 3)	(806,544)	(218)
Equity method investments	(2,768)	(9,829)
Proceeds from sale of property and equipment	1,834	132
Terminated forward contract	3,535	0
Net cash used in investing activities	(845,514)	(41,200)
Cash flows from financing activities
Termination of cash flow hedge	21,252	0
Repurchase of common stock	(74,562)	(24,125)
Proceeds from borrowing under lines of credit and term loan	716,721	8,530
Repayments of lines of credit and capital leases	(27,816)	(8,632)
Debt issuance costs	(6,804)	(819)
Dividends paid	(32,819)	(30,815)
Cash paid on behalf of employees for shares withheld	(9,523)	(5,397)
Net cash provided by (used in) financing activities	586,449	(61,258)
Effect of exchange rate changes on cash and cash equivalents	3,776	(99)
Net increase in cash and cash equivalents	8,107	19,541
Cash and cash equivalents at beginning of period	301,155	274,639
Cash and cash equivalents at end of period	309,262	294,180
Noncash activity during the period
Noncash capital expenditures	681	550
Dividends declared but not paid	11,223	10,847
Issuance of Company’s common stock for compensation	$ 960	$ 692